Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Capricor Therap (CAPR)

Capricor Therap (CAPR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 115,801
  • Shares Outstanding, K 23,022
  • Annual Sales, $ 310 K
  • Annual Income, $ -13,660 K
  • 60-Month Beta 6.49
  • Price/Sales 351.27
  • Price/Cash Flow N/A
  • Price/Book 3.44
Trade CAPR with:

Options Overview

Details
  • Implied Volatility 109.73%
  • Historical Volatility 76.53%
  • IV Percentile 1%
  • IV Rank 9.34%
  • IV High 208.20% on 09/18/20
  • IV Low 99.58% on 09/02/21
  • Put/Call Vol Ratio 0.83
  • Today's Volume 1,384
  • Volume Avg (30-Day) 455
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 11,379
  • Open Int (30-Day) 6,631

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.20
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.79 +32.72%
on 08/19/21
5.32 -5.45%
on 09/03/21
+1.06 (+26.70%)
since 08/17/21
3-Month
3.79 +32.72%
on 08/19/21
6.22 -19.18%
on 06/22/21
-0.03 (-0.59%)
since 06/17/21
52-Week
3.13 +60.70%
on 05/13/21
8.40 -40.12%
on 02/10/21
-0.86 (-14.60%)
since 09/17/20

Most Recent Stories

More News
Capricor Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases,...

CAPR : 5.03 (+6.34%)
Capricor: Q2 Earnings Snapshot

BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Thursday reported a loss of $4.7 million in its second quarter.

CAPR : 5.03 (+6.34%)
Capricor Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

CAP-1002 - Capricor's Cell Therapy Program for Duchenne Muscular Dystrophy

CAPR : 5.03 (+6.34%)
Capricor Therapeutics to Present Second Quarter 2021 Financial Results and Recent Corporate Update on August 12

Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases,...

CAPR : 5.03 (+6.34%)
Capricor Announces Joint Publication with the US Army Institute of Surgical Research for Cardiosphere-Derived Exosomes as a Potential Therapeutic for Shock

-Preclinical Data Demonstrates Capricor's Exosome Product as an Antishock Therapeutic if Delivered Early

CAPR : 5.03 (+6.34%)
Capricor Therapeutics Announces the Appointment of Karimah Es Sabar to its Board of Directors

Capricor Therapeutics ("Capricor" or "the Company") (NASDAQ: CAPR), a biotechnology company focused on developing transformative cell and exosome-based therapeutics for treating and preventing a broad...

CAPR : 5.03 (+6.34%)
Thinking about buying stock in Arcus Biosciences, Capricor Therapeutics, Orphazyme, Sundial Growers, or Citius Pharmaceuticals?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RCUS, CAPR, ORPH, SNDL, and CTXR.

ORPH : 4.76 (+3.48%)
SNDL : 0.7254 (+0.85%)
CAPR : 5.03 (+6.34%)
CTXR : 2.08 (unch)
RCUS : 36.39 (+10.17%)
Thinking about buying stock in ConforMIS, Citius Pharmaceuticals, Clover Health, Capricor Therapeutics, or Dare Bioscience?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CFMS, CTXR, CLOV, CAPR, and DARE.

CFMS : 1.8300 (+0.55%)
CLOV : 8.31 (+2.09%)
CAPR : 5.03 (+6.34%)
CTXR : 2.08 (unch)
DARE : 1.7700 (+4.73%)
Strength Seen in Capricor (CAPR): Can Its 5.7% Jump Turn into More Strength?

Capricor (CAPR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road....

CAPR : 5.03 (+6.34%)
Capricor Therapeutics to Present Findings from HOPE-2 Open-Label Extension Study at Parent Project Muscular Dystrophy (PPMD) 2021 Virtual Annual Conference

Capricor Therapeutics ("Capricor" or "the Company") (NASDAQ: CAPR), a biotechnology company focused on developing transformative cell and exosome-based therapeutics for treating and preventing a broad...

CAPR : 5.03 (+6.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Capricor Therapeutics, Inc. is a biotechnology company. It is focused on the development of novel therapeutics to prevent and treat heart disease. The Company has two drug candidates in development: Cenderitide and CU-NP. Capricor Therapeutics, Inc., formerly known as Nile Therapeutics, Inc., is based...

See More

Key Turning Points

3rd Resistance Point 5.47
2nd Resistance Point 5.25
1st Resistance Point 5.14
Last Price 5.03
1st Support Level 4.81
2nd Support Level 4.59
3rd Support Level 4.48

See More

52-Week High 8.40
Fibonacci 61.8% 6.39
Fibonacci 50% 5.76
Fibonacci 38.2% 5.14
Last Price 5.03
52-Week Low 3.13

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar